NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Adverse events were mostly mild and resolved spontaneously.

Clinical Trials 251

Clinical Trials Chronic Pain Cannabinoids Patients 251

The Cannigma

NOVEMBER 23, 2021

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects.

Data 52

Data Patients Access Wellness and Beauty 52

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Veriheal

SEPTEMBER 16, 2022

Medical cannabis can be consumed in a variety of ways to reduce pain. Recent research has found that aerosolized cannabis can provide long-term pain reduction, specifically in patients with neuropathy and other chronic conditions. This device ensures that patients get metered and precise doses of cannabis.

Patients 120

Patients Chronic Pain Research and Development Treatment 120

Cannabis Law Report

JUNE 1, 2021

The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. billion, servicing nearly 340,000 active patients. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JUNE 16, 2021

As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. a global leader in the cannabis industry serving both medical and consumer markets and dedicated to helping people improve their lives.

Programs 100

Programs Data Events Collective 100

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. To start, participants reported that psilocybin had helped them process emotions tied to painful events in their past.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety 52

Safety Cannabinoids Events Data 52

Veriheal

JULY 12, 2021

Fortunately, congressional committees are fighting for medical cannabis access for veterans , and states are beginning to take measures to address their veterans , but what is the latest in research and what can one expect? At this time, there is little in the way for combat-related PTSD treatment specifically. Let’s find out. .

Treatment 104

Treatment Sleep Clinical Trials Data 104

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

SEPTEMBER 2, 2022

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant.

THC 105

THC Pets Events Hemp 105

The Joint Blog

APRIL 17, 2020

Cannabis Sativa, a.k.a Its psychoactive ingredient, THC, has made cannabis a highly used recreational drug for millennia. Over the past few decades, there has been an increased interest in leveraging cannabis and cannabinoids for medicinal purpose. marijuana” is the one of the most popular illicit substances in the world.

Events 48

Events THC Chronic Pain Sleep 48

The Blunt Truth

FEBRUARY 24, 2022

Supreme Court asked the Justice Department to weigh in on reimbursements for medical cannabis. To start with the bad news, a House bill that would have decriminalized, regulated and taxed cannabis went down to defeat this week. Further bulletins as events warrant, and they always seem to warrant in the Mount Rushmore state.

Decriminalization 111

Decriminalization Hemp Data Agriculture 111

The Cannigma

OCTOBER 21, 2021

ADHD has long been tied to increased cannabis use, as well as abuse of drugs like alcohol and nicotine. Still, many patients report that cannabis helps them to feel more in control of their symptoms, leading to important questions. Can cannabis help with ADHD? Can cannabis help with ADHD? What is ADHD? 6 7 8 9.

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137

The Cannigma

MARCH 25, 2021

Like many people who are drawn to work with and advocate for medical cannabis , I first saw the difference that cannabis can make with someone very close to me. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis. Transfering nurses’ skills to cannabis medicine.

Patients 145

Patients Clinical Trials Medicine Events 145

Veriheal

SEPTEMBER 15, 2021

Cannabis is increasingly being researched in various capacities. In order for you to better understand the many types of cannabis research, this guide has been put together for your convenience. In order for you to better understand the many types of cannabis research, this guide has been put together for your convenience.

Data 95

Data Collective Environment Cannabis 95

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical 52

Pharmaceutical Cannabinoids Treatment Clinical Trials 52

Cannabis Law Report

JULY 19, 2021

The data from the study is expected to be embedded into the RYAH MD platform, with the goal of enabling healthcare professionals to administer THC, CBD and terpenes in milliliters, which are then expected to automatically be converted into milligrams to allow for a customized, targeted patient inhalation session. “Our

Therapy 76

Therapy Data Research and Development Events 76

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. THC is the primary psychoactive compound in cannabis.) 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

Puff Puff Post

SEPTEMBER 16, 2019

16, 2019 /CNW/ – Québec doctors have a new tool at their disposal for learning about medical cannabis and its viability as a treatment option for their patients. Logo : Santé Cannabis and Spectrum Therapeutics, the medical division of Canopy Growth (CNW Group/Canopy Growth Corporation). MONTREAL and SMITHS FALLS, ON, Sept.

Programs 108

Programs Research and Development Education Treatment 108

Illinois News Joint

APRIL 2, 2023

One of the comments we get most, especially after publishing monthly cannabis sales totals, is, “Where’s all that tax money going?” According to the CROO website, the Illinois Department of Revenue posts monthly updates how the Cannabis Regulation Fund gets distributed. For more Illinois cannabis industry news, visit here.

Education 84

Education Cannabis Collective Programs 84

SpeedWeed

MARCH 13, 2021

Almost 25% of patients with Parkinson’s disease reported that they had used cannabis in the prior six months in a survey from the Parkinson’s Foundation. However, common treatments do not address the non-motor symptoms and can sometimes cause side effects including dyskinesia, an abnormality or impairment of voluntary movement. .

Patients 52

Patients Treatment Therapy Sleep 52

Cannabis Law Report

AUGUST 17, 2021

(Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

The Joint Blog

MARCH 3, 2021

According to a new study published in the Journal of Cannabis Research, adjunctive marijuana use is associated with improvements in pain and other symptoms in patients with refractory fibromyalgia. The study is titled Medical cannabis for the treatment of fibromyalgia syndrome: A retrospective, open-label case series.

Therapy 61

Therapy Hybrid Marijuana Research and Development 61

Cannabis Law Report

JANUARY 23, 2022

I was a young cannabis research student on my first trip overseas to an international research conference. Events like these afford us a glimpse into the future of research and medicine in this field. At current, transplant treatments are hindered by our understanding of the immune response of those receiving treatments.

Research and Development 52

Research and Development Wellness and Beauty Patients CBD 52

The Joint Blog

JANUARY 3, 2020

Marijuana-based medicines “might be effective and safe in the treatment of tics and comorbidities” in those with Gilles de la Tourette Syndrome, according to a new study published in the journal Cannabis and Cannabinoids Research and e-published by the National Institute of Health.

Data 49

Data Treatment Marijuana Patients 49

Cannabis Law Report

AUGUST 10, 2021

The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% It is an honour and privilege to be in the position to use novel psychedelic treatments to solve the complex puzzle that is chronic pain. These statements relate to future events or future performance. billion in 2030. 3 Psychol Res Behav Manag.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

SpeedWeed

SEPTEMBER 18, 2021

The admonitions come after months of rising consumer demand and poison control reports associated with the cannabinoid, which is naturally found in the Cannabis sativa plant. Specifically, the Michigan Poison Control Center reported two cases of severe adverse events to delta-8 in the two children who ingested a parent’s delta-8 gummies.

Blood Pressure 76

Blood Pressure Business Concentrates Events 76

Cannabis Law Report

JULY 22, 2021

We believe that this will serve as a strong platform from which to deploy impactful alternative and psychedelic based treatment options,” stated Pouya Farmand, Chief Executive Officer of Levitee. About Levitee Labs. Levitee Labs is establishing itself as a leader in the integrative wellness space.

eCommerce 105

eCommerce Therapy Media Access 105

Cannabis Law Report

DECEMBER 9, 2021

Johnson recently reported his interim results at Microdose’s Psychedelic Medicine Business Event, from his current smoking cessation study, utilizing a single macro-dose of psilocybin. Mydecine has been working closely with Dr. Johnson and JHU to advance their lead drug candidate MYCO-001 as a smoking cessation treatment.

Clinical Trials 52

Clinical Trials Research and Development Therapy Treatment 52

SpeedWeed

FEBRUARY 24, 2021

Federal cannabis legalization has never felt closer, even though the newly elected President of the United States has repeatedly voiced opposition. Forcing someone convicted of cannabis possession to choose between rehab and prison makes no sense. Study Finds Cannabis Dispensaries Reduce Opioid Deaths by 21%.

Treatment 52

Treatment Data Programs Decriminalization 52

SpeedWeed

SEPTEMBER 18, 2021

The admonitions come after months of rising consumer demand and poison control reports associated with the cannabinoid, which is naturally found in the Cannabis sativa plant. Specifically, the Michigan Poison Control Center reported two cases of severe adverse events to delta-8 in the two children who ingested a parent’s delta-8 gummies.

Blood Pressure 70

Blood Pressure Concentrates Events THC 70

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98